Genome-wide association studies have identified hundreds of robust genetic associations
underlying psychiatric disorders and provided important biological insights into disease …

Over 90% of drug candidates fail in clinical trials, while it takes 10–15 years and one billion
US dollars to develop a single successful drug. Drug development is more challenging for …

Substance use disorders represent a significant public health concern with considerable
socioeconomic implications worldwide. Twin and family-based studies have long …

There is widespread overlap across major psychiatric disorders, and this is the case at
different levels of observations, from genetic variants to brain structures and function and to …

Background Roughly more than one in six adults worldwide suffer from psychiatric
conditions. Sporadic studies have associated parental psychiatric disorders with autism …

Background Integrating quantitative trait loci (QTL) data related to molecular phenotypes
with genome-wide association study (GWAS) data is an important post-GWAS strategic …

All powerful technology has the potential to cause harm. Genomic testing is no exception.
How, you might reasonably ask, can such a seemingly innocuous procedure cause harm …

As the world faces the challenge of increasing sustainable food production for a growing
population amidst climate change and limited resources, animal breeders must double meat …